About Us

Who We Are

The International Cytokine & Interferon Society (ICIS), is a non-profit organization of over 850 scientists devoted to research in the fields of cytokine, interferon and chemokine cell biology, molecular biology, biochemistry and the clinical use of these biological response modifiers. Bringing together scientists across many different research disciplines, ICIS is the premier organization promoting the field of cytokine biology, impacting all aspects of medicine and leading to new treatments in autoimmune diseases, cancer, infectious diseases and inflammation. A common ground where scientists interested in all aspect of cytokine biology can join and work together to better human health.

The role of and effect of cytokines in every aspect of human health will continue to be identified and characterized and the use of cytokines themselves or antibodies to cytokines will become even more important tools in the arsenal of clinicians. Thus, the importance of the ICIS as a focal point for cytokine research will only continue to grow. Tadatsugu Taniguchi – Past President (2017-2019)

It is a  major goal of the ICIS to facilitate interactions between young investigators and trainees with established researchers in the interferon and cytokine field. Outstanding junior investigators, postdoctoral researchers, and graduate/medical students are encouraged to participate in the Annual Scientific meeting through the presentation of prestigious travel awards dedicated to young researchers.

A Family of Cytokine Biologists

Become a part of the world-wide community of scientists devoted to research in the fields of cytokine, interferon, and chemokine biology by joining the International Cytokine & Interferon Society. Join others in this large field to exchange information and ideas, strengthen interdisciplinary ties, and build international collaborations. The Society serves as a network to facilitate research communication and strengthen links between academic, government and industry scientists to advance the therapeutic use of and targeting of cytokines, their commercialization and the success of biological response modifiers.

Mission

The mission shall be to:

  • to promote original research in the fields of cytokines, interferons, chemokines, growth factors and their receptors;
  • to facilitate communication and interaction between scientists aimed at the multidisciplinary integration of current basic and clinical knowledge and concepts in these areas of research;
  • to facilitate interactions between young investigators and trainees with established researchers in the interferon and cytokine field;
  • to promote the dissemination of information on, and applications of knowledge of theses areas of biomedical research;
  • to promote an awareness with educational programs of the national and international health communities of the importance of these areas of biomedical research.

To achieve these goals, the Society will sponsor meetings, publications and other educational activities.

Signals+ Volume 7, No. 1

View the latest issue of Signals+

253 total views, 1 views today

4 Days until the Abstract Deadline for the TNF Super Family Meeting 2019 – the 17th TNF Conference June 3-7, 2019 Asilomar, Monterey, CA

4 Days until the Abstract Deadline for the 17th TNF Conference June 3-7, 2019 Asilomar, Monterey, CA

234 total views, no views today

The Nomination Deadlines for Awards in Cytokine & Interferon Research are Approaching

Nomination Deadline Approaching for the 2019 Seymore & Vivian Milstein Award for Excellence in Interferon & Cytokine Research & the ICIS-BioLegend William E. Paul Award for Excellence in Cytokine Research

396 total views, no views today

Cancer Associated Inflammation: Role of Cytokines and Interferons, JICR FREE Issue through February 5, 2019.

In this special issue, several leaders in the field discuss the latest developments in our understanding of cancer-associated inflammation, with a focus on the role of inflammatory cytokines and interferons. Emphasis is also placed on identifying opportunities and developing road maps for novel treatment approaches to combine immunotherapies with direct modulation of cytokine levels in the host.

271 total views, 1 views today

3,102 total views, 2 views today